The class B drug has some very nasty effects on the body ...
On its fourth-quarter earnings conference call on Jan. 21, Johnson & Johnson JNJ announced its financial outlook for 2026, ...
Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a single-center study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results